Type Whole antibody ChemSpider none | ATC code none | |
![]() | ||
Bivatuzumab mertansine is a combination of bivatuzumab, a humanized monoclonal antibody, and mertansine, a cytotoxic agent. It is designed for the treatment of squamous cell carcinoma.
References
Bivatuzumab mertansine Wikipedia(Text) CC BY-SA